Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Canagliflozin Hemihydrate: Transforming Type 2 Diabetes Care services provided by Suanfarma

Suanfarma
Canagliflozin Hemihydrate: Transforming Type 2 Diabetes Care

PDF Upload Mar, 2025

Suanfarma Appoints Pere Mañé as New CEO to Lead Global Expansion

22 Apr 2025

// PRESS RELEASE

Sustainability in Pharma Manufacturing: Path to Greener Future

16 Apr 2025

// PRESS RELEASE

Pharma APIs Storage: Ensuring Quality and Compliance

14 Apr 2025

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Suanfarma

Contact Supplier

CPhI North America

Booth #1219

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.youtube.com/embed/9IzvFN6AABg

Xls

CATEGORY PAGE

Suanfarma

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Suanfarma Appoints Pere Mañé as New CEO to Lead Global Expansion, Canagliflozin Hemihydrate: Transforming Type 2 Diabetes Care, Strategic Rebranding Initiative under Suanfarma CDMO, Human API Product List 2024, Veterinary API Product List 2024, Intermediates Product List 2024, Strategic Cooperation for Anti-infective & Antibacterial APIs, Large Volume Anti-infective APIs Through Precision Fermentation

Product List 2024
Suanfarma Appoints Pere Mañé as New CEO to Lead Global Expansion
Canagliflozin Hemihydrate: Transforming Type 2 Diabetes Care
Strategic Rebranding Initiative under Suanfarma CDMO
Human API Product List 2024
Veterinary API Product List 2024
Intermediates Product List 2024
Strategic Cooperation for Anti-infective & Antibacterial APIs
Large Volume Anti-infective APIs Through Precision Fermentation

VIDEO(s)

Corporate Video

Corporate Video

DIGITAL CONTENT

10 Corporate Content #SupplierSpotlight, 2 Data Compilation #PharmaFlow, 77 News #PharmaBuzz

10 Corporate Content #SupplierSpotlight
2 Data Compilation #PharmaFlow
77 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

18 All APIs, 5 USDMF, 4 CEP/COS, 1 JDMF, 1 KDMF, 3 NDC API, 1 VMF, 18 Listed APIs

18 All APIs
5 USDMF
4 CEP/COS
1 JDMF
1 KDMF
3 NDC API
1 VMF
18 Listed APIs

INTERMEDIATES

46 ALL Intermediates

46 ALL Intermediates

KEY PRODUCTS

Anastrozole, Bisoprolol Fumarate, Canagliflozin, Clomiphene Citrate, Fluralaner, Levosimendan, Lymecycline, Minocycline Hydrochloride, Opicapone, Oxytetracycline Calcium, Oxytetracycline Dihydrate, Oxytetracycline Hydrochloride, Ribociclib, Rivaroxaban, Tetracycline, Tetracycline Hydrochloride, Tiamulin Fumarate, Trimebutine Maleate

Anastrozole
Bisoprolol Fumarate
Canagliflozin
Clomiphene Citrate
Fluralaner
Levosimendan
Lymecycline
Minocycline Hydrochloride
Opicapone
Oxytetracycline Calcium
Oxytetracycline Dihydrate
Oxytetracycline Hydrochloride
Ribociclib
Rivaroxaban
Tetracycline
Tetracycline Hydrochloride
Tiamulin Fumarate
Trimebutine Maleate

SERVICES

API Manufacturing

API Manufacturing

KEY SERVICES

Small Molecule API Manufacturing, Microbial Fermentation for Small Molecules, API Clinical Supply

Small Molecule API Manufacturing
Microbial Fermentation for Small Molecules
API Clinical Supply

INSPECTIONS & REGISTRATIONS

13 FDA, 9 EDQM

13 FDA
9 EDQM

PI91625

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!